Figure 1.
Increased expression of USP17 is observed in non-small cell lung cancer cells treated with cisplatin. Increasing concentrations of cisplatin increased the protein expression level of USP17 in a dose-dependent manner, as shown in (A) western blot images and the (B) corresponding histogram, in A549 cells; and (C) western blot images and the (D) corresponding histogram, in H1299 cells. USP, ubiquitin-specific peptidase.